Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Botella JA, Bayersdorfer F, Schneuwly S
To explore differences in (i) past-year use of GLP-1 or GLP-1/GIP medication to support weight loss and (ii) interest in using a weight-loss medication in the next year between population subgroups, we estimated these proportions stratified by gender, age, ethnicity, occupational social grade, financial situation, health-related economic inactivity, smoking status, alcohol consumption, past-month distress, and history of eating disorders
Crosstalk between Gut Microbiota and host immune system and its response to traumatic injury
Tofacitinib as induction and maintenance therapy for ulcerative colitis
Many patients are surprised to learn that the number on the scale doesnt tell the whole story
US$ 21.29
US$ 22.35
US$ 25.95
US$ 21.30
US$ 24.80
US$ 22.19
